Romosozumab biosimilar (Jiuyuan Gene)

N/A

Report date: 2024/06/21 14:45:05

Base Information

Drug NameRomosozumab biosimilar (Jiuyuan Gene)
Drug Alias Name罗姆单抗生物类似药（九源基因）JY41JY-41
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Biosimilar
Mechanisms of ActionSclerostin inhibitors
TargetsSclerostin
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Jiuyuan Gene Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Jiuyuan Gene Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A